PHGE Gross Margin

The Gross Margin of Biomx Inc (PHGE) is 7775.20%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

PHGE Gross Margin - Historical Value

Date	Value
2024-12-31	7775.20%

PHGE Gross Margin - Peers Comparison

Ticker	Name	Value
ABEO	Abeona Therapeutics Inc	100.00%
ATOS	Atossa Therapeutics Inc	100.00%
IMV.TO	IMV Inc	7775.20%
ONC.TO	Oncolytics Biotech Inc	7775.20%
CELC	Celcuity Inc	7775.20%
ENOB	Enochian Biosciences Inc	100.00%
FENC	Fennec Pharmaceuticals Inc	93.30%
LPTX	Leap Therapeutics Inc	7775.20%
PSTI	Pluristem Therapeutics Inc	100.00%
BCLI	Brainstorm Cell Therapeutics Inc	7775.20%
SYBX	Synlogic Inc	7775.20%
TARA	Protara Therapeutics Inc	7775.20%
XFOR	X4 Pharmaceuticals Inc	68.83%
ALRN	Aileron Therapeutics Inc	7775.20%
APTX	Aptinyx Inc	7775.20%
ATNF	180 Life Sciences Corp	7775.20%
DMAC	DiaMedica Therapeutics Inc	7775.20%
DYAI	Dyadic International Inc	65.82%
AYLA	Old Ayala Inc	-
OBSV	Obseva SA	7775.20%
AXLA	Axcella Health Inc	7775.20%
GLTO	Galecto Inc	7775.20%
NBSE	NeuBase Therapeutics Inc	-900.00%
AEZS.TO	Aeterna Zentaris Inc	95.06%
ENLV	Enlivex Therapeutics Ltd	7775.20%
NYMX	Nymox Pharmaceutical Corp	-
PTN	Palatin Technologies Inc	97.83%